← Leaderboards
Kay-Uwe Wagner
Wayne State University
$7,933,901
Attributed
$7,933,901
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $716.5K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,933,901 · 9
By mechanism
R01$6,998,869 · 3
R21$355,287 · 1
P20$242,483 · 3
P30$184,470 · 1
R03$152,792 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Growth”
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$233,131,631
- Albert Lazzarini · California Institute Of Technology$170,110,000
- David H Reitze · University Of Florida$170,110,000
- Garret A Fitzgerald · University Of Pennsylvania$153,184,124
- David Heimbrook · Leidos Biomedical Research, Inc.$143,966,408
- Carol Nesel · Westat$116,355,411
Research focus
GrowthSignal TransductionAblationMediatingMalignant NeoplasmsNeoplastic CellTherapeutic TargetBiologicalCancer CellNeoplasticPreventMolecularGenesTumor ProgressionMemberComplexOncogenicReceptorPropertyIn VivoMutationTumorEventMammary Gland
Grant awards (41)
Tumor Biology and Microenvironment$30,238
P30 · FY2025 · CA · contact PI
Tumor Biology and Microenvironment$52,358
P30 · FY2024 · CA · contact PI
Tumor Biology and Microenvironment$31,051
P30 · FY2023 · CA · contact PI
Tumor Biology and Microenvironment$39,772
P30 · FY2022 · CA · contact PI
JAK1 Signaling in Pancreatic Cancer Initiation and Progression$306,715
R01 · FY2021 · CA · contact PI
Tumor Biology and Microenvironment$31,051
P30 · FY2021 · CA · contact PI
JAK1 Signaling in Pancreatic Cancer Initiation and Progression$309,271
R01 · FY2020 · CA · contact PI
JAK1 Signaling in Pancreatic Cancer Initiation and Progression$301,594
R01 · FY2019 · CA · contact PI
JAK1 Signaling in Pancreatic Cancer Initiation and Progression$248,005
R01 · FY2018 · CA · contact PI
JAK1 Signaling in Pancreatic Cancer Initiation and Progression$117,233
R01 · FY2018 · CA · contact PI
Targeting the PTAP Domain of TSG101 in ERBB2-associated Mammary Cancer$77,000
R03 · FY2018 · CA · contact PI
JAK1 Signaling in Pancreatic Cancer Initiation and Progression$340,193
R01 · FY2017 · CA · contact PI
Targeting the PTAP domain of TSG101 in ERBB2-associated mammary cancer$75,792
R03 · FY2017 · CA · contact PI
Growth-Regulatory Signaling Networks in Breast Cancer$255,944
R01 · FY2016 · CA · contact PI
Growth-Regulatory Signaling Networks in Breast Cancer$255,944
R01 · FY2015 · CA · contact PI
Growth-Regulatory Signaling Networks in Breast Cancer$248,265
R01 · FY2014 · CA · contact PI
Tsg101 - a Modulator of ErbB2 Signaling in Breast Cancer$242,413
R01 · FY2013 · CA · contact PI
Growth-Regulatory Signaling Networks in Breast Cancer$240,588
R01 · FY2013 · CA · contact PI
Tsg101 - a Modulator of ErbB2 Signaling in Breast Cancer$257,887
R01 · FY2012 · CA · contact PI
Growth-Regulatory Signaling Networks in Breast Cancer$255,944
R01 · FY2012 · CA · contact PI
Temporally controlled oncogene expression in a novel pancreatic cancer model$161,494
R21 · FY2012 · CA · contact PI
Tsg101 - a Modulator of ErbB2 Signaling in Breast Cancer$257,887
R01 · FY2011 · CA · contact PI
Temporally controlled oncogene expression in a novel pancreatic cancer model$193,793
R21 · FY2011 · CA · contact PI
COBRE: UNE MED CTR: CORE C: HISTOLOGY CORE$88,664
P20 · FY2011 · RR · contact PI
Tsg101 - a Modulator of ErbB2 Signaling in Breast Cancer$265,863
R01 · FY2010 · CA · contact PI
Growth-Regulatory Signaling Networks in Breast Cancer$253,359
R01 · FY2010 · CA · contact PI
COBRE: UNE MED CTR: CORE C: HISTOLOGY CORE$89,173
P20 · FY2010 · RR · contact PI
COBRE: UNE MED CTR: CORE B: MOUSE GENOME ENGINEERING$64,646
P20 · FY2010 · RR · contact PI
Tsg101 - a Modulator of ErbB2 Signaling in Breast Cancer$265,863
R01 · FY2009 · CA · contact PI
Growth-Regulatory Signaling Networks in Breast Cancer$253,359
R01 · FY2009 · CA · contact PI
Tsg101 - a Modulator of ErbB2 Signaling in Breast Cancer$197,273
R01 · FY2009 · CA · contact PI
Growth-Regulatory Signaling Networks in Breast Cancer$253,359
R01 · FY2008 · CA · contact PI
Growth-Regulatory Signaling Networks in Breast Cancer$253,359
R01 · FY2007 · CA · contact PI
Growth-Regulatory Signaling Networks in Breast Cancer$260,925
R01 · FY2006 · CA · contact PI
Tumor Susceptibility Gene 101 Deficiency and Neoplasia$255,511
R01 · FY2006 · CA · contact PI
Tumor Susceptibility Gene 101 Deficiency and Neoplasia$261,660
R01 · FY2005 · CA
Tumor Susceptibility Gene 101 Deficiency and Neoplasia$9,958
R01 · FY2005 · CA
Tumor Susceptibility Gene 101 Deficiency and Neoplasia$296,774
R01 · FY2004 · CA
Tumor Susceptibility Gene 101 Deficiency and Neoplasia$9,958
R01 · FY2004 · CA
Tumor Susceptibility Gene 101 Deficiency and Neoplasia$261,660
R01 · FY2003 · CA
Tumor Susceptibility Gene 101 Deficiency and Neoplasia$262,105
R01 · FY2002 · CA